Agilon Health Faces Class Action Over Misleading Business Information
Written by Emily J. Thompson, Senior Investment Analyst
Source: Globenewswire
Updated: 53 minutes ago0mins
- Potential Lawsuit Investigation: The Rosen Law Firm is investigating potential securities claims against Agilon Health (NYSE: AGL) for allegedly issuing materially misleading business information, indicating possible concealment of critical information from investors that could harm shareholder interests.
- Stock Price Plunge: Following the announcement on August 5, 2025, to suspend its full-year 2025 financial guidance, Agilon Health's stock plummeted by 51.5%, reflecting extreme pessimism in the market regarding the company's future outlook.
- Class Action Preparation: The Rosen Law Firm is preparing a class action for affected investors, allowing them to seek compensation without any out-of-pocket costs, which may further pressure Agilon Health's financial standing.
- Law Firm's Advantage: The Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, showcasing its strength and experience in handling similar cases.
AGL.N
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
No Data
Powered By
Intellectia
Analyst Views on AGL
Wall Street analysts forecast AGL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AGL is 1.15 USD with a low forecast of 0.50 USD and a high forecast of 1.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
2 Buy
7 Hold
2 Sell
Hold
Current: 0.728
Low
0.50
Averages
1.15
High
1.50
Current: 0.728
Low
0.50
Averages
1.15
High
1.50
Bernstein
Market Perform
downgrade
2025-12-04
New
Reason
Bernstein
Price Target
2025-12-04
New
downgrade
Market Perform
Reason
Bernstein lowered the firm's price target on Agilon Health to 88c from $1.40 and keeps a Market Perform rating on the shares. The firm updated its Agilon model forward to reflect Q3 results, lowering its price target due to high prior period medical costs and increased costs for exited markets. The firm added that it remains positive on the sector turnaround and its impacts on Agilon.
RBC Capital
Sector Perform -> Outperform
upgrade
$10 -> $11
2025-12-03
New
Reason
RBC Capital
Price Target
$10 -> $11
2025-12-03
New
upgrade
Sector Perform -> Outperform
Reason
RBC Capital upgraded AGL Energy to Outperform from Sector Perform with a price target of A$11, up from A$10. The firm cites the company's growing battery fleet and retail tariff tailwinds for the upgrade.
Evercore ISI
Elizabeth Anderson
In Line
downgrade
$1
2025-11-05
Reason
Evercore ISI
Elizabeth Anderson
Price Target
$1
2025-11-05
downgrade
In Line
Reason
Evercore ISI analyst Elizabeth Anderson lowered the firm's price target on Agilon Health to 50c from $1 and keeps an In Line rating on the shares. Q3 results were weaker than anticipated and the reinstated 2025 guidance suggests a challenging Q4 ahead, the analyst tells investors.
Bernstein
Lance Wilkes
Outperform -> Market Perform
downgrade
$4
2025-08-20
Reason
Bernstein
Lance Wilkes
Price Target
$4
2025-08-20
downgrade
Outperform -> Market Perform
Reason
Bernstein analyst Lance Wilkes downgraded Agilon Health to Market Perform from Outperform with a price target of $1.40, down from $4. The firm cites the company's worse than expected margin pressure for the downgrade. Agilon's margin challenges reduce its capital cushion and increases its cost of capital, which creates an uncertain growth outlook, the analyst tells investors in a research note. Bernstein does not see the company as representing a strategically valuable asset that could be attractive to buyers.
See All Ratings
About AGL
agilon health, inc. is a healthcare company. It enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.
About the author
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sigh Up to Get Intellectia Insights
Why did Agilon Health's stock drop by 51.5% in August 2025?
What are the key allegations against Agilon Health in the class action?
How might Agilon Health's stock perform after the class action resolution?
What could be the long-term financial impact of the lawsuits on Agilon Health?